Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2013 1
2014 2
2015 5
2016 5
2017 11
2018 11
2019 9
2020 13
2021 19
2022 10
2023 4
2024 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Results by year

Filters applied: . Clear all
Page 1
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial.
Herrlinger U, Tzaridis T, Mack F, Steinbach JP, Schlegel U, Sabel M, Hau P, Kortmann RD, Krex D, Grauer O, Goldbrunner R, Schnell O, Bähr O, Uhl M, Seidel C, Tabatabai G, Kowalski T, Ringel F, Schmidt-Graf F, Suchorska B, Brehmer S, Weyerbrock A, Renovanz M, Bullinger L, Galldiks N, Vajkoczy P, Misch M, Vatter H, Stuplich M, Schäfer N, Kebir S, Weller J, Schaub C, Stummer W, Tonn JC, Simon M, Keil VC, Nelles M, Urbach H, Coenen M, Wick W, Weller M, Fimmers R, Schmid M, Hattingen E, Pietsch T, Coch C, Glas M; Neurooncology Working Group of the German Cancer Society. Herrlinger U, et al. Among authors: renovanz m. Lancet. 2019 Feb 16;393(10172):678-688. doi: 10.1016/S0140-6736(18)31791-4. Epub 2019 Feb 14. Lancet. 2019. PMID: 30782343 Free article. Clinical Trial.
Editorial: Quality of care of glioma patients.
Forster MT, De Witt Hamer P, Hervey-Jumper SL, Renovanz M. Forster MT, et al. Among authors: renovanz m. Front Neurol. 2022 Oct 6;13:1041388. doi: 10.3389/fneur.2022.1041388. eCollection 2022. Front Neurol. 2022. PMID: 36277924 Free PMC article. No abstract available.
Loss of H3K27me3 in meningiomas.
Nassiri F, Wang JZ, Singh O, Karimi S, Dalcourt T, Ijad N, Pirouzmand N, Ng HK, Saladino A, Pollo B, Dimeco F, Yip S, Gao A, Aldape KD, Zadeh G; International Consortium on Meningiomas. Nassiri F, et al. Neuro Oncol. 2021 Aug 2;23(8):1282-1291. doi: 10.1093/neuonc/noab036. Neuro Oncol. 2021. PMID: 33970242 Free PMC article.
Editorial: Autoimmune complications of modern cancer therapies.
Möhn N, Renovanz M, Hagin D, Skripuletz T. Möhn N, et al. Among authors: renovanz m. Front Immunol. 2024 Jan 5;14:1357825. doi: 10.3389/fimmu.2023.1357825. eCollection 2023. Front Immunol. 2024. PMID: 38250085 Free PMC article. No abstract available.
Depatux-M and temozolomide in advanced high-grade glioma.
Hirsch S, Roggia C, Biskup S, Bender B, Gepfner-Tuma I, Eckert F, Zips D, Malek NP, Wilhelm H, Renovanz M, Tabatabai G. Hirsch S, et al. Among authors: renovanz m. Neurooncol Adv. 2020 Jun 6;2(1):vdaa063. doi: 10.1093/noajnl/vdaa063. eCollection 2020 Jan-Dec. Neurooncol Adv. 2020. PMID: 32705082 Free PMC article. No abstract available.
Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma.
Wang JZ, Patil V, Landry AP, Gui C, Ajisebutu A, Liu J, Saarela O, Pugh SL, Won M, Patel Z, Yakubov R, Kaloti R, Wilson C, Cohen-Gadol A, Zaazoue MA, Tabatabai G, Tatagiba M, Behling F, Almiron Bonnin DA, Holland EC, Kruser TJ, Barnholtz-Sloan JS, Sloan AE, Horbinski C, Chotai S, Chambless LB, Gao A, Rebchuk AD, Makarenko S, Yip S, Sahm F, Maas SLN, Tsang DS; International Consortium on Meningiomas (ICOM); Rogers CL, Aldape K, Nassiri F, Zadeh G. Wang JZ, et al. Nat Med. 2024 Nov;30(11):3173-3183. doi: 10.1038/s41591-024-03167-4. Epub 2024 Aug 21. Nat Med. 2024. PMID: 39169220 Free PMC article.
Towards more Diversity in Neuro-oncology Leadership-the DivINe Initiative.
Kurz SC, Stammberger A, Rosahl SK, Abrey LE, Albert NL, von Baumgarten L, Gempt J, Grosu AL, Leidgens V, McLean A, Renovanz M, Schwarzenberger J, Sevenich L, Urbanic Purkart T, Combs SE, Tabatabai G, Hegi M, Nowosielski M. Kurz SC, et al. Among authors: renovanz m. Neuro Oncol. 2023 Dec 8;25(12):2302-2304. doi: 10.1093/neuonc/noad157. Neuro Oncol. 2023. PMID: 37738478 Free PMC article. No abstract available.
Resilience in Lower Grade Glioma Patients.
Fröhlich E, Sassenrath C, Nadji-Ohl M, Unteroberdörster M, Rückriegel S, von der Brelie C, Roder C, Forster MT, Schommer S, Löhr M, Pala A, Goebel S, Mielke D, Gerlach R, Renovanz M, Wirtz CR, Onken J, Czabanka M, Tatagiba MS, Rohde V, Ernestus RI, Vajkoczy P, Gansland O, Coburger J. Fröhlich E, et al. Among authors: renovanz m. Cancers (Basel). 2022 Nov 2;14(21):5410. doi: 10.3390/cancers14215410. Cancers (Basel). 2022. PMID: 36358828 Free PMC article.
The outcomes measured and reported in intracranial meningioma clinical trials: A systematic review.
Millward CP, Keshwara SM, Armstrong TS, Barrington H, Bell S, Brodbelt AR, Bulbeck H, Dirven L, Grundy PL, Islim AI, Javadpour M, Koszdin SD, Marson AG, McDermott MW, Meling TR, Oliver K, Plaha P, Preusser M, Santarius T, Srikandarajah N, Taphoorn MJB, Turner C, Watts C, Weller M, Williamson PR, Zadeh G, Zamanipoor Najafabadi AH, Jenkinson MD; EORTC BTG, ICOM, EANO, SNO, RANO-PRO, BNOS, SBNS, BIMS, TBTC, International Brain Tumour Alliance, Brainstrust, and Brain Tumour Foundation of Canada. Millward CP, et al. Neurooncol Adv. 2024 Mar 2;6(1):vdae030. doi: 10.1093/noajnl/vdae030. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 38596717 Free PMC article.
Clinical outcome of biomarker-guided therapies in adult patients with tumors of the nervous system.
Renovanz M, Kurz SC, Rieger J, Walter B, Becker H, Hille H, Bombach P, Rieger D, Grosse L, Häusser L, Skardelly M, Merk DJ, Paulsen F, Hoffmann E, Gani C, Neumann M, Beschorner R, Rieß O, Roggia C, Schroeder C, Ossowski S, Armeanu-Ebinger S, Gschwind A, Biskup S, Schulze M, Fend F, Singer S, Zender L, Lengerke C, Brucker SY, Engler T, Forschner A, Stenzl A, Kohlbacher O, Nahnsen S, Gabernet G, Fillinger S, Bender B, Ernemann U, Öner Ö, Beha J, Malek HS, Möller Y, Ruhm K, Tatagiba M, Schittenhelm J, Bitzer M, Malek N, Zips D, Tabatabai G. Renovanz M, et al. Neurooncol Adv. 2023 Feb 14;5(1):vdad012. doi: 10.1093/noajnl/vdad012. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 36915613 Free PMC article.
83 results